MYCN is a crucial driver gene in the childhood cancer neuroblastoma as illustrated by overexpression due to genomic amplification in a large subset of high risk tumors and formation of neuroblastoma in MYCN-driven transgenic mouse and zebrafish model systems [33]–[37]. This evidence concerns the gene MYCN and neuroblastoma.